Aktuella utlysningar, vecka 41, 2023
Grants Office tipsar om aktuella utlysningar
Svenska och nordiska anslag
Dessa främjar vetenskaplig forskning och undervisning eller studieverksamhet i Sverige rörande prostatacancer och bröstcancer.
Closing date: November 1, 2023.
Forskningsanslag - Stiftelsen Apotekare Hedbergs fond för medicinsk forskning och Bertil och Ebon Norlins stiftelse för medicinsk forskning
Stiftelsen Apotekare Hedbergs fond för medicinsk forskning och Bertil och Ebon Norlins stiftelse för medicinsk forskning avser att dela ut sammanlagt cirka 2 miljoner kronor för avancerad medicinsk forskning i Sverige. Stiftelserna kommer att prioritera projekt inom områdena inflammatoriska sjukdomar och neurologiska sjukdomar. Beloppet kommer att fördelas mellan högst 10 sökanden.
Closing date: November 15, 2023
Resebidrag - Svensk Onkologisk Förening
Resebidrag kan sökas av föreningens medlemmar för deltagande i internationella vetenskapliga möten. Stipendiesumman är på 15 000 kr.
Closing date: Ansökan kan skickas in under hela året. Beslutsdatum är fyra gånger per år: den 31 januari, den 31 maj, den 31 augusti och den 30 november.
Travel Grant - Svenska Sällskapet för Medicinsk Forskning (SSMF)
SSMF offers travel stipends for doctoral students who are carrying out preclinical and clinical medical research in Sweden. The stipend is for a maximum of SEK 50,000 and is awarded a maximum of three times. Doctoral students registered at a Swedish university with at least one peer-reviewed publication to their names are eligible to apply for the travel grant.
Closing date: December 1, 2023.
Gästforskarstipendier - Wenner-Gren Stiftelserna
Gästforskarstipendier ger svenska forskare möjlighet att bjuda in utländska forskare att verka vid en svensk vetenskaplig institution. Behöriga att söka är svenska forskare. De besökande forskarna ska vara seniora forskare som ha avlagt doktorsexamen tidigare än fem år före ansökningstillfället. Stipendierna beviljas för mellan en till 12 månaders tid, och är avsedda för att utgöra en ersättning för de merkostnader som gästen ådrar sig genom att förlägga sin verksamhet till Sverige.
Closing date: March 10, 2024
SSF Sabbatical – Swedish Foundation for Strategic Research (SSF)
The program gives researchers the opportunity to take one to two sabbatical years abroad where the research will take place in a different discipline or sector than the person currently works in. The research must be within SSF’s priority areas: natural science, technology or medicine. The purpose of the call is to give the researcher the opportunity to broaden their horizons, both internationally and multidisciplinary, and thus to open up to new bold ideas and ways of thinking at home.
Closing date: March 5, 2024
Pandemic preparedness and response: Host-pathogen interactions of infectious diseases with epidemic potential: HORIZON-HLTH-2024-DISEASE-08-20
Call details: Research and Innovation Action, €7-8 million per project
As shown by the COVID-19 pandemic, infectious diseases remain a major threat to health and health security in the EU and globally. Viral disease emergence is expected to accelerate due to among other factors, climate change, and thus a proactive approach to the development of vaccines and inhibitors for the cellular uptake of viruses in preparedness for future infectious disease outbreaks is needed. The availability of vaccines and candidates that inhibit cellular uptake of viruses would provide a critical preparedness measure against future health threats, in particular against pathogens with high pandemic potential meeting the criteria identified by the Health Emergency Preparedness and Response Authority (HERA).
Proposals should follow innovative approaches to characterise host-pathogen interactions with a view to inhibit viral replication, viral proteases, viral exit strategies and to develop therapeutic antibodies and vaccines that target viruses with high epidemic or pandemic potential for the EU. Proposals should focus on the following viruses: Hendra and Nipah virus, Lassa virus, Crimean Congo haemorrhagic fever virus, Rift Valley fever virus, Ebola and Marburg virus, Dengue virus, Yellow Fever virus, Zika virus, West Nile fever virus and Chikungunya virus. Proposal should take into account sex and gender aspects.
Closing date: 11 April 2024
The role of mainstream media, social media and marketing in fostering healthy and sustainable consumption patterns and how to encourage good practices: HORIZON-CL6-2024-GOVERNANCE-01-3
Call details: Coordination and Support Actions, €3 million per project
Food consumption cannot be considered the sole responsibility of citizens or a problem of demand only since it is a result of a choice that is influenced by culture, social and economic factors and where the food environment plays an important role. In todays’ interconnected world, the impacts of mainstream media, social media and digital marketing are amplified, with food influencers, NGOs and social platforms making citizens think differently about food. As studies show, since eating habits are also influenced by what consumers see, being virtually surrounded by healthy eaters may encourage consumers to eat healthier. However, the reverse is also true.
In addition, differences in media and marketing (both linear and non-linear) approaches of national/regional/local governments, civil society, and the private sector, can lead to differences in consumption patterns and food choices across different socio-economic and cultural groups. Moreover, television viewing and internet use has led to a more inactive, sedentary lifestyle, as well as more exposure to the marketing of products high in fat, sugar and/or salt among adults and children. Greater levels of TV viewing and internet use is associated with harmful effects on the eating habits of children. This includes higher consumption levels of products high in fat, sugar and/or salt. An improved understanding of these differences and drivers of food choices can support all food systems operators and actors to develop innovative and effective communication strategies (and related policy and regulatory frameworks) that would benefit all parts of the society and support a shift towards healthy and sustainable diets for all.
Closing date: 28 February 2024
International grants. ROLE OF GUT MICROBIOTA IN THE MECHANISMS OF PAIN - Biocodex Microbiota Foundation
The Biocodex Microbiota Foundation invites applications for its international grants. These support clinical or fundamental research projects focused on human gut microbiota related to health and disease. For the current round, projects must focus on the role of gut microbiota in the mechanisms of pain.
Budget: The grant is worth €200,000 over one to three years. 10% INDI coverage max.
Closing date: 30 November 2023
Fellowship Award - European Society for Paediatric Infectious Disease (ESPID)
The goal of the fellowship award is to stimulate basic or clinical research that utilizes advanced techniques and methods to improve the health of children by prevention or management of infectious diseases.
The maximum total support offered is €110,000. The support is intended to help provide personal support for the fellow (salary, tuition fees and other direct personal costs including travel costs for the fellow +/- her/his family between home and the host institution if required). It may not be used to provide resources for a division's research programme through payment for research materials and consumables, other salaries, nor to pay indirect costs to the host or home institution.
Closing date: 1 December 2023
New call (9th round) for Eurolife Postdoc Mobility and Knowledge Exchange grants
Eurolife utlyser för nionde gången Eurolife Postdoc Mobility and Knowledge Exchange Grants för 2024. Satsningen görs för att stimulera ytterligare forskningssamarbete inom Eurolife genom att erbjuda bidrag på 1 500 EUR för att täcka rese- och boendekostnader under en utbytesperiod på minst 2 veckor mellan 1 mars och 31 december 2024.
Sista ansökningsdag: 1 december 2023
Travel awards for collaboration between KI researchers, doctoral students, postdocs and UK universities
Deadline: 22 October 2023
Collaboration with Kings College London
Collaboration with Imperial College London
Travel awards for collaboration with the University of Edinburgh
NIH - HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
Funding Opportunity ID: PAR-24-037
Upcoming deadlines: Full application - 13th March, 2024
Abstract: The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included. The HIV Vaccine Research and Design (HIVRAD) Program supports projects that address hypotheses crucial to the design of an efficacious HIV/AIDS prophylactic vaccine. An application submitted in response to this Notice of Funding Opportunity (NOFO) should include hypothesis-supporting data that the research has advanced past the exploratory stage, including preliminary immunogenicity to justify the vaccine candidate development; and the application should lay out a research plan with clear decision points. Preclinical evaluation of vaccine concepts in nonhuman primates and/or small animal models, such as transgenic humanized mice, may be included.
NIH - Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
Funding Opportunity ID: RFA-DA-24-032
Upcoming deadlines: Full application - 16th January, 2024
Abstract: This notice of funding opportunity (NOFO) seeks clinical research applications that propose to identify and validate new non-invasive brain stimulation (NIBS) e.g., Transcranial Magnetic Stimulation, Transcranial Direct or Alternating Current Stimulation targets for Substance Use Disorder (SUD) and SUD-relevant neurobiological, cognitive, or behavioral response to NIBS that may precede clinical outcomes like reduced craving or substance use. Together these goals seek to provide a more complete understanding of the cognitive, behavioral, and neurobiological effects of neuromodulation. Such studies should lead to stronger mechanistic understanding of circuit-level dysfunction in SUD as well as indices of NIBS response that may precede long term clinical symptom relief.
NIH - Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
Funding Opportunity ID: RFA-DA-25-059
Upcoming deadlines: Full application - 20th August, 2024
Abstract: The purpose of this notice of funding opportunity (NOFO) is to support the development and testing of enhanced models of care that optimally integrate HIV, Hepatitis B and C, addiction, and primary care services. The National Institute on Drug Abuse (NIDA) is interested in research that addresses gaps related to the delivery of comprehensive, integrated health services to include the full continuum of HIV/AIDS services, addiction prevention and treatment services, and primary care services, with a goal of improving the coordination of care, and improving health outcomes related to HIV, Hepatitis (optional), and substance use disorder (SUD) in the US.
NIH - Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed)
Funding Opportunity ID: RFA-DA-25-011
Upcoming deadlines: Full application - 14th August, 2024
Abstract: This notice of funding opportunity (NOFO) will support high risk high impact studies that 1) develop or apply novel tools or technologies or 2) test novel hypotheses to investigate mechanistic questions in HIV infection, replication, latency, and/or pathogenesis (including neuroHIV) in the context of Substance Use Disorders (SUDs). This initiative focuses on exploration and characterization of signaling pathways that are involved in CNS HIV establishment and expansion. The NOFO aims to promote milestone-driven research to investigate the underlying molecular mechanisms by which HIV infection is initiated, established, and maintained in the CNS and to determine how addictive substances modulate HIV infection, latency and the size and persistence of CNS HIV reservoirs.
The Leukemia & Lymphoma Society (LLS), US - Specialized Center of Research Program
Upcoming deadlines: LOI - continuous deadline; Full application - by invitation
Amount: Up to $5,000,000. $1,000,000 per year for a maximum of 5 years. The maximum annual indirect cost is $150,000.00 (15% of total annual costs).
Eligibility: Applicants must hold a PhD, MD, DVM, or equivalent degree and must be affiliated with
a non-profit Institution at the time funding commences and for the duration of the award. Applications may involve multiple institutions.
Abstract: A major emphasis in the SCOR grant program is on clinical translation of scientific results. Ideally, a SCOR application will propose a combination of basic and translational laboratory research that will lead to eventual clinical translation. There should be clear and direct “bench to bedside” translational trajectory from one or more of the Projects in the SCOR. It is important to note that the inclusion of a clinical trial in and of itself may not satisfy this requirement. Any clinical translation must be a coherent and integrated extension of other SCOR activities, and there should be substantive interactions and synergy between clinical trials and more basic or early translational Projects in the SCOR. Each SCOR Program is comprised of 3-5 scientific Projects, 2-5 supportive Cores, including an administrative Core. There must be objective evidence of interdisciplinary research and the potential for synergism by linking the various Projects and Cores into a SCOR team. The quality and significance of the Projects and Cores and the enhanced productivity that is likely to be achieved by linking investigators are primary determinants of funding decisions. A SCOR team will be judged as a unit and funding will not be available for otherwise meritorious but non-synergistic parts of an application.
Alzheimer’s Association (AA), US - Funding Program for Global Real-World Data Platforms (ALZ-RWD)
Upcoming deadlines: LOI - continuous deadline; Full application - by invitation
Amount: Up to $1,000,000. Project length 12-24 months. Indirect costs are not covered by this grant.
Eligibility: Principal Investigators must hold a full-time faculty position or full-time paid position of the organization submitting the proposal. Investigators that have received Alzheimer’s Association funding for a related or other study and are currently delinquent in submitting required reports or have awards closed as “Incomplete” are not eligible to apply.
Abstract: The collection of Real-World Data (RWD) is integral to the discovery, evaluation and evolution of novel avenues for the diagnosis, prevention, treatment and care of Alzheimer’s and other dementia. Furthermore, RWD can play a key role in the identification and understanding of health disparities, and the subsequent development and implementation of initiatives to advance health equity. RWD platforms house data on patient health status and health care collected within real-world settings. To support the advancement of and opportunities for RWD platforms, the Alzheimer’s Association is launching a peer-reviewed funding program to augment and accelerate global initiatives aimed at developing, expanding and aligning RWD platforms’ infrastructure, data and impact.
Intuitive Foundation, US - Research Grants
Upcoming deadlines: LOI - 5th January 2024; Full Application - 5th April 2024
Amount: $75,000 maximum, up to 1 year in duration. Total costs may include no more than 20% indirect costs.
Eligibility: Multiple grants will not be funded simultaneously to any principal investigator. Grants are awarded to principal investigators at their institution.
Clinical Research Grants
The purpose of these grants is to support clinical research at non-profit institutions worldwide focused on the field of robotic-assisted surgery. Successful proposals will study important questions related to surgical care and patient outcomes. The Intuitive Foundation has identified key research areas of interest for the 2024-2025 clinical grant programs. Principal Investigators are encouraged – although not required – to submit proposals that fall into one or more of the following areas: Clinical Outcomes-Based Research; Imaging, Vision and/or Navigational Research; Health Economic and Outcomes Research including Cost-effectiveness and Cost-utility Studies related to Robotic-assisted Surgery; and/or New Procedure Exploration and Development Research.
Training and Human Performance Research Grant
The purpose of these grants is to support training and human performance research in the field of surgery and robotic-assisted surgery. Successful proposals will address important questions about assessing intraoperative performance, accelerating skill acquisition while preserving patient safety, and maintaining skill proficiency of surgical team members. The Intuitive Foundation also supports proposals that apply scalable technology to improve global access to surgical training. The Foundation has identified three key areas of interest for the 2024-2025 Training and Human Performance Research Grants. Principal investigators are encouraged, although not required, to submit proposals that fall into one or more of the following areas: Introducing robotic-assisted and computer-assisted technologies to surgeons, surgical teams, and surgical departments in ways that minimize disruption and maximize productivity; Enhancing teamwork in the operating room; and/or Addressing shortages of surgeons and surgical staff.
Travel awards for collaboration with the University of Tokyo for doctoral students and post docs
Deadline 30 October 2023